These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1934538)
41. Blood pressure during a combination of ketanserin and hydrochlorothiazide. Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636 [TBL] [Abstract][Full Text] [Related]
42. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker. Rosenthal J; Koehle W; Gruebel B; Fisher R J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145 [TBL] [Abstract][Full Text] [Related]
43. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs. Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685 [TBL] [Abstract][Full Text] [Related]
45. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol. Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519 [TBL] [Abstract][Full Text] [Related]
46. Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension. Ito K; Omae T; Ikeda M; Iimura O; Yoshinaga K; Ishii M; Kaneko Y; Mizuno Y; Masuyama Y; Takeda T Drugs; 1988; 36 Suppl 1():18-24. PubMed ID: 3071459 [TBL] [Abstract][Full Text] [Related]
47. Ketanserin and captopril interaction in the treatment of essential hypertensives. Lavezzaro G; Ladetto PE; Valente M; Stramignoni D; Zanna C; Assogna G; Salvetti A Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():119-22. PubMed ID: 2285641 [TBL] [Abstract][Full Text] [Related]
48. Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects. de Divitiis O; Galderisi M; Celentano A; Tammaro P; Garofalo M; Palmieri V; Crivaro M; Assogna G; Zanna C J Int Med Res; 1993; 21(3):113-25. PubMed ID: 8299854 [TBL] [Abstract][Full Text] [Related]
49. Use of ketanserin in the treatment of hypertension following coronary artery surgery. Vandenbroucke G; Foubert L; Coddens J; DeLoof T; Evenepoel MC J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):324-9. PubMed ID: 8061266 [TBL] [Abstract][Full Text] [Related]
50. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H Am J Cardiol; 1989 Apr; 63(12):826-32. PubMed ID: 2648788 [TBL] [Abstract][Full Text] [Related]
51. Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial. Rossouw HJ; Howarth G; Odendaal HJ S Afr Med J; 1995 Jun; 85(6):525-8. PubMed ID: 7652635 [TBL] [Abstract][Full Text] [Related]
52. Oral dosing with ketanserin to control high blood pressure in the elderly. van Oene JC Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():111-4. PubMed ID: 2285639 [TBL] [Abstract][Full Text] [Related]
53. Chronic effect of ketanserin in mild to moderate essential hypertension. Woittiez AJ; Wenting GJ; van den Meiracker AH; Ritsema van Eck HJ; Man in't Veld AJ; Zantvoort FA; Schalekamp MA Hypertension; 1986 Feb; 8(2):167-73. PubMed ID: 2935497 [TBL] [Abstract][Full Text] [Related]
54. Prolongation of the QT interval by ketanserin. Cameron HA; Waller PC; Ramsay LE Postgrad Med J; 1988 Feb; 64(748):112-7. PubMed ID: 3050936 [TBL] [Abstract][Full Text] [Related]
55. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin. Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801 [TBL] [Abstract][Full Text] [Related]
56. Double-blind comparison of ketanserin and propranolol in hypertensive patients. Staessen J; Fagard R; Lijnen P; Rorive G; Amery A J Cardiovasc Pharmacol; 1988 Dec; 12(6):718-25. PubMed ID: 2467091 [TBL] [Abstract][Full Text] [Related]
57. Effects of short-term ketanserin treatment on the QT interval and vagal function in healthy subjects. Stott DJ; Robertson JI; McLenachan JM; Ball SG J Auton Pharmacol; 1989 Feb; 9(1):45-51. PubMed ID: 2722900 [TBL] [Abstract][Full Text] [Related]
58. A placebo-controlled crossover study of ketanserin in elderly hypertensive patients. McCarthy ST; McCarthy GL; John SM; Gould SE Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():115-7. PubMed ID: 2285640 [TBL] [Abstract][Full Text] [Related]